Sylphar partners with Arash and Babak Peyami and welcomes two digital native brands in its portfolio, Pro Teeth Whitening and Nutravita.
Deurle (Belgium), 6 September 2018 – Sylphar, the fast-growing OTC platform which teamed-up with Vendis Capital in May 2017, has acquired Pro Teeth Whitening and Nutravita, two digital native brands respectively active in teeth whitening and food supplements.
Founded by two young entrepreneurs, Arash and Babak Peyami, Pro Teeth Whitening and Nutravita are two UK-based ecommerce companies which, within a few years, have succeeded in building leading positions online in their respective categories.
Pro Teeth Whitening offers premium and 100% natural teeth whitening products based on the scientifically proven properties of activated charcoal. Nutravita designs and distributes a range of 100% natural supplements which help you on your journey for a healthier mind, body & soul. All products are made in UK.
Arash and Babak Peyami join the management of Sylphar and will lead the ecommerce efforts of the group going forward.
Founder and CEO of Sylphar, Robin List explains: “We are very happy to welcome Arash, Babak and their teams to the group and are convinced that the companies and people involved complement each other perfectly. Arash and Babak will bring their unique experience and knowledge of ecommerce and will benefit from our product range, innovation capabilities and the full support of our organization.”
Arash Peyami adds: “We are excited to become part of the Sylphar family. By combining our strengths, we are giving ourselves the means to match our ambitions and to further accelerate both the growth of Pro Teeth Whitening and Nutravita offline and the roll-out of Sylphar’s products online.”
Babak Peyami concludes “It is a major step forward for us; we have been impressed by the professionalism and acumen of the Sylphar team which gives us nothing but confidence for working together in the future.”
The acquisition of Pro Teeth Whitening and Nutravita perfectly matches Sylphar’s strategy to become one of the leading branded and omni-channel European players in the consumer healthcare space and confirms the buy & build ambitions Robin List and Vendis Capital together agreed on.